Wenxue Lin
Clinical Assistant Professor
• B.S., Biotechnology, Dalian Medical University, China, 2014
• M.S., Materials Science and Engineering, Washington State University, 2016
• M.S., Epidemiology, University of Oklahoma Health Sciences Center, 2019
• Ph.D., Epidemiology, Pennsylvania State University College of Medicine, 2022
Dr. Wenxue Lin is a Clinical Assistant Professor in the Department of Epidemiology and Biostatistics at the School of Public Health–Bloomington, Indiana University. He earned his B.S. in Biotechnology from Dalian Medical University in China (2014), his M.S. in Materials Science and Engineering from Washington State University (2016), his M.S. in Epidemiology from the University of Oklahoma Health Sciences Center (2019), and his Ph.D. in Epidemiology from the Pennsylvania State University College of Medicine (2022).
Prior to joining Indiana University, Dr. Lin served for three years as an Assistant Professor of Instruction in the Department of Epidemiology and Biostatistics at Temple University, where he taught and mentored both undergraduate and graduate students.
Dr. Lin’s research focuses on tobacco control, with an emphasis on reduced nicotine content cigarettes. He has examined two randomized controlled trials evaluating the impact of reduced nicotine content cigarettes on smoking behavior and tobacco exposure biomarkers, particularly among populations experiencing tobacco-related health disparities, such as individuals with low socioeconomic status or mood and anxiety disorders. In addition to clinical trial research, Dr. Lin has conducted secondary analyses using multiple large-scale epidemiologic datasets, including the Population Assessment of Tobacco and Health (PATH), Behavioral Risk Factor Surveillance System (BRFSS), Health Information National Trends Survey (HINTS), and the National Health and Nutrition Examination Survey (NHANES).
Lin, Wenxue, Junjia Zhu, John E. Hayes, John P. Richie, and Joshua E. Muscat. "Comparison of carcinogen biomarkers in smokers of menthol and nonmenthol cigarettes: The 2015–2016 National Health and Nutrition Examination Survey Special Sample." Cancer Epidemiology, Biomarkers & Prevention 31, no. 8 (2022): 1539-1545.
Lin, Wenxue, Nicolle M. Krebs, Junjia Zhu, Kimberly Horn, Jonathan Foulds, A. Eden Evins, and Joshua E. Muscat. "Racial Differences in Nicotine Reduction: Pooled Results from Two Double-Blind Randomized Controlled Trials." Journal of Racial and Ethnic Health Disparities (2024): 1-6.
Lin, Wenxue. "Knowledge of the health consequences of heavy alcohol consumption among individuals with different substance use statuses: a cross-sectional analysis of 2019 HINT survey." Chronic Illness 21, no. 2 (2025): 253-262.
Lin, Wenxue, Sydney A. Martinez, Kai Ding, and Laura A. Beebe. "Knowledge and perceptions of tobacco-related harm associated with intention to quit among cigarette smokers, e-cigarette users, and dual users: findings from the US Population Assessment of Tobacco and Health (PATH) Wave 1." Substance use & misuse 56, no. 4 (2021): 464-470.
Lin, Wenxue, Andrea L. Hobkirk, Junjia Zhu, Nicolle M. Krebs, John E. Hayes, John P. Richie Jr, Jason Liao, Kimberly Horn, Jonathan Foulds, and Joshua E. Muscat. "Effect of menthol on nicotine reduction: Pooled results from two double-blind randomized controlled trials." Brain research bulletin 189 (2022): 131-138.